Readoutin 14d
Guangdong Hengrui Pharmaceutical Co., Ltd — SHR-1819 Injection
Phase 3 primary completion: A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Seasonal Allergic Rhinitis